Dynatronics (NASDAQ:DYNT) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Dynatronics (NASDAQ:DYNTGet Rating) in a report issued on Sunday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

DYNT has been the subject of a number of other research reports. Roth Capital reiterated a “buy” rating on shares of Dynatronics in a report on Thursday, February 17th. TheStreet lowered Dynatronics from a “c-” rating to a “d+” rating in a research note on Friday, February 11th. Finally, Zacks Investment Research downgraded Dynatronics from a “hold” rating to a “sell” rating in a research report on Tuesday, May 17th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $2.13.

Shares of Dynatronics stock opened at $0.71 on Friday. The stock has a market cap of $12.90 million, a price-to-earnings ratio of -70,900.00 and a beta of -0.01. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.89 and a current ratio of 2.03. The stock has a 50 day moving average price of $0.69 and a 200-day moving average price of $0.86. Dynatronics has a one year low of $0.43 and a one year high of $1.79.

Dynatronics (NASDAQ:DYNTGet Rating) last announced its earnings results on Thursday, May 12th. The medical equipment provider reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09). Dynatronics had a return on equity of 2.99% and a net margin of 1.11%. Sell-side analysts predict that Dynatronics will post -0.24 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Renaissance Technologies LLC grew its holdings in shares of Dynatronics by 36.8% in the fourth quarter. Renaissance Technologies LLC now owns 1,096,365 shares of the medical equipment provider’s stock worth $1,096,000 after purchasing an additional 295,200 shares during the last quarter. Millennium Management LLC bought a new position in shares of Dynatronics in the third quarter worth about $120,000. Citadel Advisors LLC bought a new position in shares of Dynatronics in the third quarter worth about $30,000. Finally, Goldman Sachs Group Inc. bought a new position in shares of Dynatronics in the third quarter worth about $56,000. Hedge funds and other institutional investors own 19.46% of the company’s stock.

Dynatronics Company Profile (Get Rating)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.

See Also

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.